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Abstract
Background: The importance of enhancing influenza resistance in domestic flocks is quite clear both scientifically
and economically. Chicken is very susceptible to influenza virus. It has been reported that human cellular
cyclophilin A (CypA) impaired influenza virus infection in 293T cells. Whether chicken CypA (chCypA) inhibits
influenza virus replication is not known. The molecular mechanism of resistance in chicken to influenza virus
remains to be studied.
Results: The chCypA gene was isolated and characterized in the present study. It contained an ORF of 498 bp
encoding a polypeptide of 165 amino acids with an estimated molecular mass of 17.8 kDa sharing high identity
with mammalian CypA genes. The chCypA demonstrated an anti-influenza activity as expected. ChCypA protein
was shown to be able to specifically interact with influenza virus M1 protein. Cell susceptibility to influenza virus
was reduced by over-expression of chCypA in CEF cells. The production of recombinant influenza virus A/WSN/33
reduced to one third in chCypA expressing cells comparing to chCypA absent cells. ChCypA was widely distributed
in a variety of chicken tissues. It localized in cytoplasm of chicken embryo fibroblast (CEF) cells. Avian influenza
virus infection induced its translocation from cytoplasm into nucleus. ChCypA expression was not significantly up-
regulated by avian influenza virus infection. The present study indicated that chCypA was an inhibitory protein to
influenza virus replication, suggesting a role as an intrinsic immunity factor against influenza virus infection.
Conclusion: The present data demonstrates that chCypA possesses anti-influenza virus activity which allows the
consideration of genetic improvement for resistance to influenza virus in chickens.
Background
In chicken, influenza A virus infection causes a wide spec-
trum of symptoms, ranging from mild illness to a highly
contagious and rapidly fatal disease resulting in severe epi-
demics, which not only cause great economic loss for
poultry industry but also pose threat to public health.
It is hypothesized that the major cell determinant of
resistance to influenza virus is absence of the counter
receptors on cell surface. Therefore the viral haemagglu-
tinin is not able to access such cells to initiate first step
of infection. However, it has been reported recently that
both SAa2, 6-Gal and SAa2, 3-Gal receptors are pre-
sent in many organs of birds, pigs and humans [1-4].
The susceptibility to influenza virus of different host
species varies greatly suggesting existence of inhibitory
mechanisms beyond the receptor-virus interaction.
Multiple layers of defence systems are present in host
cells to either block entrance or inhibit viral replication
during the course of infection. In the present study
chicken cellular protein chCypA was proven to be such
a host factor inhibitory to influenza virus infection and
replication. Our study suggests the ubiquitous protein
serves as a defensive mechanism against influenza virus
infection.
It has been shown that CypA is incorporated into
influenza virus virion [5] and the expression of CypA is
up-regulated upon infection by avian influenza virus in
a human gastric carcinoma cell line [6]. CypA exhibits
an inhibitory activity to influenza virus replication in the
early stage of infection by interfering newly synthesized
M1 protein translocation into nucleus [7].
Cyclophilin A is a multifunctional protein which is the
major cytosolic binding protein of the immunosuppressive
drug cyclosporin A. CypA has a chaperone-like activity
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important roles in protein folding, trafficking, assem-
bly, immune-modulator and cell signalling. CypA also
involves in pathogenesis in several diseases including
cancer, cardiovascular disease and viral infection. Sev-
eral studies suggest an essential or inhibitory role for
CypA in the replication of several viruses including
human immunodeficiency virus type 1, vesicular sto-
matitis virus, vaccinia virus, hepatitis C virus and
human papillomavirus type 1 [8-17].
To determine whether chCypA possesses the similar
anti-influenza activity as human CypA, chCypA was iso-
lated and characterized and the relevance of chCypA to
influenza virus infection was revealed. The discovery
that chCypA inhibited influenza virus replication may
lead to consideration of genetic improvement in chicken
for resistance to influenza virus. Comprehensive knowl-
edge of host restriction factors to influenza virus
infection could provide valuable insight into the molecu-
lar mechanisms of viral replication and cellular defensive
response to virus infection.
Results
cDNA cloning, sequence analysis of chCypA and
functional sites prediction
The full length ORF of chCypA was composed of 498
bp [GenBank: GQ849480] encoding a polypeptide of
165 amino acids with a predicted molecular mass of
17.8 kDa. The isoelectric point of chCypA predicted
with DNAStar program was 8.07. The deduced amino
acid sequences shared homology with those of human
CypA and bovine CypA were 90.3% and 90.2% respec-
tively, the homology between the mammalian CypAs is
over 96% (Figure 1B).
Although chCypA shared 90.3% amino acid homology
with human CypA, polyclonal antibodies against human
Figure 1 Alignment of deduced amino acid sequence of chCypA homology from different species. A, Amino acid residues aligned by the
CLUSTALW program. The residues that match the consensus exactly were shown with “.”, the Cyp-type peptidyl-prolyl cis-trans isomerase
signatures and the well conserved CsA binding sites were shadowed; the amino acids necessary for the peptidylprolyl cis-trans isomerase activity
were marked with"*"; thirteen CsA binding residues were boxed. B, Homology identity between chCypA and other species cyclophilin A.
GenBank accession numbers are: P62937 (human), P62940 (rhesus monkey), P17742 (mouse), P62935 (cattle), P14832 (baker’s yeast).
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shown), which suggested an antigenic difference exist
between human CypA and chicken CypA. Results ana-
lysed by DNAStar protean software suggested the high
antigenicity region was mostly localized in amino acid
residues from 147 to 155 within chCypA where showing
high surface probability and high antigenic index. The
different antigenicity could be explained by the fact that
most different amino acids between chCypA and human
CypA were also localized within this region (Figure 1A).
It has been reported that chCypA with Mr18 kDa and
pI 8.2 [18], approximate to Mr17.8 kDa and pI 8.07
which we predicted from ORF sequence with DNAStar
program. Rabbit polyclonal antibodies against chCypA
generated with purified hexahistidine-tagged chCypA
(His-chCypA) could detect endogenous 18 kDa protein
confirming the gene isolated was indeed chicken
cyclophilin A. There were two amino acid residues
(Pro12Ala, Thr20Val) different from our gene in partial
chCypA reported by Caroni [19]. The peptidylprolyl cis-
trans isomerase active site (residues His54, Arg55,
Phe60, Gln111, Phe113, Trp121) and thirteen CsA con-
tact residues (Arg55, Phe60, Met61, Gln 63, Gly72,
Ala101, Asn102, Ala103, Gln111, Phe113, Trp121,
Leu122 and His126) were exactly same among the
sequences aligned (Figure 1A).
ChCypA interacted with influenza virus M1 protein
To detect whether chCypA directly interacted with M1
protein, GST pull-down assay and co-immunoprecipi-
tation were performed. The specific interaction of M1
and chCypA in vivo was determined by co-immuno-
precipitation with proteins transient expressed in 293T
cell. As shown in Figure 2A, Myc-chCypA could be
co-immunoprecipited with Flag-M1 by anti-Flag mono-
clonal antibody. In GST pull-down assay, His-M1
fusion protein or CEF cell lysate infected with avian
influenza virus A/Chicken/Liaoning/1/00(H9N2) was
incubated with an equal amount of GST alone or
GST-chCypA recombinant protein bound to glutathio-
nesepharose 4B beads. After washing extensively, the
His-M1 or M1 protein bound to the beads was
extracted and analysed by Western blot with anti-His-
tag or anti-M1 monoclonal antibody. As shown in
Figure 2B, the M1 protein was associated with GST-
chCypA, but not GST alone. GST pull-down and co-
immunoprecipitation assays showed that chCypA as its
homology human CypA could specifically interact with
M1 in vitro and in vivo.
The production of recombinant A/WSN/33 virus was
reduced in over-expressing chCypA cells
12 plasmids reverse genetic system were transfected into
293T/CypA- cell with chCypA expressing plasmid
pCMV-Myc-chCypA. PCMV-Myc was used as vector
control. In chCypA over-expressing 293T/CypA- cells,
the packed A/WSN/33 virus particle production was
reduced to one-third of that in pCMV-Myc transfected
cells (p < 0.01) (Figure 3). This result suggested that
chCypA inhibited the virus replication in 293T/CypA-
cells.
ChCypA reduced cell susceptibility to A/Chicken/Liaoning/
1/00(H9N2) infection
Recombinant adenovirus carrying chCypA gene named
rAdchCypA was generated to deliver the chCypA gene
into CEF cells. Empty adenovirus rAd was also gener-
ated as vector control. Thirty hours post recombinant
adenovirus infection, CEF cells were infected with
A/Chicken/Liaoning/1/00(H9N2) at MOI = 1. 4 hours
post infection (hpi), cells were detected by immunos-
taining with anti-influenza NP polyclonal antibody and
TRITC-conjugated secondary antibody. GFP positive
Figure 2 ChCypA interacted with M1 protein of influenza virus
in vitro and in vivo. A. Co-immunoprecipitation of M1 and chCypA.
Input shows 1/10 of the total proteins included in each binding
reaction. Lane 1, pcDNA3-FLAG-M1 and pCMV-Myc-chCypA
plasmids were simultaneously transfected into 293T cells. Lane 2,
pCMV-Myc-chCypA plasmid was transfected in 293T cells. 48 h after
transfection, the cells were lysed in Hepes buffer prepared for co-
immunoprecipitation. Co-immunoprecipitation was performed using
anti-FLAG monoclonal antibody, and the proteins
immunoprecipitated (IP) were detected with an anti c-Myc
monoclonal antibody. B. GST pull-down assay was used to detect
the interaction of influenza A virus M1 protein and chCypA in vitro.
His-M1 fusion protein (1 mg) was incubated with an equal amount
of GST alone or GST-chCypA bound to glutathione-sepharose 4B
beads. After washing extensively, the His-M1 bound to the beads
was extracted and analyzed by Western blot with anti-His
antibodies. The CEF cell lysates infected by A/Chicken/Liaoning/1/00
(H9N2) were incubated with GST alone (lane GST) or GST-chCypA
(lane GST-chCypA) bound to glutathione-sepharose 4B beads. After
washing extensively, the proteins bound to the beads were
detected by Western blot analysis using anti-M1 monoclonal
antibodies. Input shows 1/10 of total M1 proteins in each binding
reaction.
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were counted under the Fluorescence Microscopy. Data
was shown in Figure 4A. In chCypA over-expression
group, there was an approximately three-fold reduction
(p < 0.05) in the proportion of the NP positive cells
relative to rAd infected CEF cells. In recombinant ade-
novirus uninfected subpopulations, i.e., GFP-negative
cells, the antigen staining was seemly enhanced relative
to rAd infected control (Figure 4A, panel below). Never-
theless, no statistic significance was found (p = 0.32)
comparing those in rAd infected with rAdchCypA
infected groups. This confirmed that the inhibition of
viral infectivity was specific to the chCypA over-
expressed cells. The cell susceptibility to influenza virus
was reduced by over-expression of chCypA was further
confirmed by the results in which over-expression of
chCypA on 293T/CypA- cells could inhibit influenza
virus M1 protein expression (Figure 4B).
ChCypA was widely distributed in all tissues detected
Tissues of three 21-day-old SPF chickens were extracted
and homogenized. 2 μg extractions of tissues were
loaded to SDS-PAGE and detected with anti-chCypA
polyclonal antibody by Western blot. Abundant chCypA
was widely distributed in all the tissues tested (Figure 5).
The relative expression level of chCypA in different tis-
sues was analyzed by comparing the intensity of bands
on X-ray films of Western blot with Photoshop soft-
ware. Intensity of chCypA in variant tissues was normal-
ized to density of bands for liver on X-ray films. Results
Figure 3 The effect of chCypA on A/WSN/33 virus production.
The inhibitory effect of chCypA on influenza virus replication was
tested by using reverse genetic system of A/WSN/33 [49]. In brief,
both a mixture of expression plasmids of PB1, PB2, PA and NP
proteins and a whole set of virus RNA expression plasmids were
transfected into 293T/CypA- cells in the presence or absence of
chCypA expression plasmid pCMV-Myc-chCypA, pCMV-Myc was
transfected as control. The supernatant was harvested 48 hpt and
titrated on MDCK cells using plaque assay. Significant differences
across control were indicated with two asterisks at P < 0.01.
Figure 4 The effect of ChCypA on avian influenza virus
infectivity. A. CEF cells were infected with chCypA-expressing
recombinant adenovirus rAdchCypA (or rAd as control) and infected
after 30 h with A/Chicken/Liaoning/1/00 (H9N2) (MOI = 1), 4 h post
influenza virus infection, cells were stained for NP (red). The
percentage of influenza virus antigen positive cells in GFP positive
population relative to that for the rAd control group was shown
below. Scale bar: 20 μm. *P < 0.05. B. ChCypA inhibited expression
of M1 protein. 293T/CypA- cells were transfected with pCMV-Myc or
pCMV-Myc-chCypA, 24 h post transfection, cells were infected with
A/Chicken/Liaoning/1/00 (H9N2) (MOI = 0.01). 6 h and 9 h post
infection, cells were harvested. Proteins were detected by Western
blot analysis using anti-b-actin, M1 and c-Myc monoclonal
antibodies as indicated. The relative expression level of M1 protein
was indicated by densitometry of M1 band on Western blot X film.
The densitometry of target protein band was analyzed with
Photoshop program.
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sion levels in spleen, bursa of Fabricius, thymus and cer-
ebella were much higher than levels expressed in other
tissues.
The temporal expression of chCypA was not significantly
up-regulated upon avian influenza virus infection
To determine whether chCypA expression responds to
influenza virus infection, the relative mRNA and protein
expression levels of chCypA in CEF cells at 0, 2, 4, 6, 8,
10, 12, and 24 hpi were measured by quantitative real
time PCR and Western blot respectively. There was
no significant increase of expression of chCypA after
A/Chicken/Liaoning/1/00(H9N2) infection (Figure 6).
Intracellular localization of chCypA changed upon
infection by A/Chicken/Liaoning/1/00(H9N2)
Intracellular localization of the chCypA was deter-
mined by indirect immunofluorescence assay to assess
the effect of influenza virus infection on chCypA trans-
location. CEF cells were trasfected with plasmid
pCMV-Myc-chCypA, 30 h post-transfection (hpt), cells
were fixed and immunostained with c-Myc polyclonal
antibody. In non-infected control, as depicted in Figure
7A, Myc-chCypA was localized predominantly in
cytoplasm. At 30 hpt, CEF cells were infected with avian
influenza virus A/Chicken/Liaoning/1/00(H9N2) (MOI =
5). At 4 hpi, Myc-chCypA and M1 were stained for green
and red respectively, as pictures shown in Figure 7B, a
large proportion of Myc-chCypA translocated into
nucleus.
Discussion
It has been demonstrated that human CypA interacts
with influenza virus M1 protein and impairs the early
stage of the viral replication [7]. In the present study,
chCypA was isolated and characterized. Results sug-
gested that the chCypA was an inhibitory protein to
influenza virus replication and infectivity. The expres-
sion of chCypA was not significantly up-regulated
upon influenza virus infection. However, a fraction of
chCypA present in cytoplasm was translocated into
nucleus upon infection of avian influenza virus in
CEF cells.
It is reported that over-expression of CypA inhibits
influenza A virus infection [7]. One hypothesis is that
different expression level of CypA in different tissues
may contribute to the resistance to influenza A virus. In
our study, the chCypA was detected in all tissues tested,
as described in other species [20-24]. The concentration
Figure 5 The distribution of chCypA in different tissues. Eighteen tissues were extracted from 21-day-old SPF chickens and relative protein
level of chCypA was determined by Western blot and relative densitometry analysis carried out with Photoshop program. 2 μg tissues extracts
were loaded into SDS-PAGE. 1, heart 2, liver, 3, spleen 4, lung 5, kidney 6, pancreas 7, brusa of Fabricius 8, esophagus 9, duodenum 10, thymus
11, cerebrum 12, cerebella 13, glandular stomach 14, gizzard 15, muscle 16, trachea 17, ovary 18, blood. Tissues of three chickens had been
extracted, and the representative data is shown.
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methods in different tissues varies in different animals
[21-25]. The relative expression of chCypA in spleen,
bursa of Fabricius, thymus and cerebella were much
higher than which in other tissues. However, there is no
obvious statistical relevance between the expression
level of chCypA and tissue specific resistance to influ-
enza virus.
It was reported that the expression of CypA in some
animals was drastically up-regulated after lipopolysac-
charides (LPS), Con A or bacteria challenged [21,23,24].
These findings suggest that CypA is a response protein
to pathogen stimulation. The current study found that
the expression of chCypA was not up-regulated by avian
influenza virus infection tested by Western blot and
quantitative real time RT-PCR. The latest findings sug-
gested that CypA expression level was up-regulated in
response to avian H9N2 virus infection in human cells
[6]. This inconformity may be explained by the degree
of host species adaptation to avian influenza virus infec-
tion. Our prediction is that human cells have not been
well adaptive to H9N2 avian influenza virus invasion. It
is possible that CypA might be up-regulated by this
virus strain infection as a response to stress.
Viruses are obligate intracellular parasites that interact
with host cell and use the host machinery for their
replication. On the other hand, there exist host factors
that restrict viral replication. The current perspectives
about host defence system, mediated by some of these
restriction factors designated as intrinsic immunity, is
distinguished from conventional innate and adaptive
immunity system as has been reviewed by Bieniaz and
Takeuchi [26-28]. Recent discoveries have revealed pre-
viously unappreciated complexity with which influenza
virus interact with their hosts [29]. In particular, we
have become aware that mammals and birds are also
equipped with genes encoding so-called “restriction fac-
tors”, that provide considerable resistance to influenza
virus infection. Heat shock cognate protein 70 (Hsc70)
inhibits the nuclear export of M1 and NP [30]. Ebp1,
ErbB3-binding protein specifically interacts with PB1
Figure 6 The temporal expression level of chCypA in CEF cells
after influenza virus infection. A. The temporal expression of
chCypA in CEF cells after influenza virus infection was measured
with Western blot analysis (MOI = 0.1). B. The temporal mRNA
relative expression level of influenza virus M1 was measured by qRT-
PCR. C. Temporal relative expression of chCypA transcripts in CEF
cells after influenza virus infection was measured by qRT-PCR.
Relative gene expression was calculated with initial normalization to
b-actin within each sample. Values are mean ± S.D. The relative
expression value was averaged from three duplicates, each of which
contains three independent samples.
Figure 7 Influenza virus infection induced nuclear localization
of chCypA. CEF cells were transfected with chCypA-expressing
plasmid pCMV-Myc-chCypA, and infected with A/Chicken/Liaoning/
1/00 (H9N2) (MOI = 5) or not (A) as control after 30 h transfection for
4 h, and were fixed and stained for Myc-chCypA (green) and M1 (red)
protein, the nucleus was stained blue with DAPI. Scale bar: 10 μm.
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feron induced proteins mouse Mx1 and human MxA
suppress influenza virus transcription by interacting
with PB2 and NP [32]. ISG15 inhibits influenza A virus
gene expression and replication [33]. Viperin inhibits
influenza virus release by perturbing lipid rafts [34]. In
the present report, we provide evidence that the ubiqui-
tous protein CypA in chicken serves as a constitutively
expressed inhibitor to influenza virus replication. There-
fore we propose host factor chCypA is involved in
intrinsic immunity against influenza virus infection. The
inhibition to influenza virus of chCypA is depended on
the interaction with M1 protein. M1 protein is well con-
served among influenza A viruses, so it is believed that
chCypA possesses inhibitory effect on broad spectrum
of influenza A viruses including highly pathogenic avian
influenza virus (HPAIV). Interestingly, CypA and Trim5
were also found to resistant to HIV-1 infection
[15,35-37]. On the other hand, CypA is required for
HCV replication [12,38]. It is noteworthy that the same
host protein can play a different role in life cycle of dif-
ferent viruses.
ChCypA displayed an essentially cytoplasm localiza-
tion and nuclear translocation upon influenza virus
infection as evidenced by indirect immunofluorescence.
Other studies also show that CypA can change location
between different cellular apartments. It is reported that
CypA phosphorylation and nuclear translocation can be
induced by ligand stimulation of chemokine receptor
CXCR4 [39]. Vaccinia virus infection can cause CypA
redistribution to viral factories [10]. We have demon-
s t r a t e dh e r et h a tc h C y p Ai si n v o l v e di ni n f l u e n z av i r u s
infection. However, little is known about the biological
significance of nuclear translocation of chCypA.
It has been reported that CypA is a proinflammatory
factor [40], implicating its potential role in cytokines
induction and anti-influenza virus activity. IFN-b plays
important roles in controlling viral infection in epithelial
cells. Among members of peptidyl-prolyl isomerase
superfamily, it is reported that cyclophilin B (CypB)
plays a critical role in interferon regulatory factor-3 acti-
vation and virus induced production of IFN-b [41].
However, it is reported Pin1, another peptidyl-prolyl iso-
merase, as a negative regulator of interferon regulatory
factor-3 dependent innate antiviral response [42]. The
peptidyl-prolyl isomerase domain of CypB and Pin1 was
required in regulation of IFN-b.B o t hc h C y p Aa n d
CypA are peptidyl-prolyl isomerases. So it is reasonable
to assume that CypA might play a role in regulation of
virus induced IFN-b production. However, it has been
proved by our group that the inhibition of influenza
virus by CypA is not depended on its isomerase activity
[7]. It is believed that NS1 protein and polymerase com-
plex of influenza A virus are potent blockers of
activation of IFN-b, However, PB1-F2 exacerbates IFN-b
expression [43-48]. The relevance between inhibitory
activity of chCypA or CypA on influenza virus replica-
tion and the regulation potential in cytokines induction
remains to be known.
The findings described in our study indicated that
chCypA exhibited an anti-influenza activity potentially
by interacting with influenza virus M1 protein, and
translocating into nucleus upon influenza infection. The
precise mechanisms of anti-influenza function of
chCypA remain to be explored. Further investigation of
molecular mechanisms of how chCypA inhibits influ-
enza virus replication may help us better understand its
anti-infection potential. The discoveries made from this
study will have some implications on a variety of scienti-
fic areas including genetic improvement for resistance to
influenza virus infection, development of viral vectors
for gene therapy and discovery of novel antiviral drug
targets.
Conclusions
This work demonstrates that chicken CypA is a well
conserved and widely distributed protein and possesses
an anti-influenza virus activity. Over-expression of
chCypA reduced A/WSN/33 virus production to one-
third of control, and inhibited influenza virus infectivity
in CEF cells. ChCypA could translocate into nucleus
from cytoplasm upon infection of influenza virus. Our
data suggested that chCypA might be an intrinsic
immunity factor to influenza virus infection.
Materials and methods
Cell lines, viruses, plasmids, and antibodies
The human embryonic kidney 293T cells, CypA gene
knockout 293T cell 293T/CypA-, CEF, Madin-Darby
canine kidney (MDCK) cells were maintained in Dulbec-
co’s modified Eagle’sm e d i u m( G I B I C O )s u p p l e m e n t e d
with 10% fetal bovine serum (GIBICO) 37°C and 5%
CO2. Wild-type influenza A virus strain A/Chicken/
Liaoning/1/00 (H9N2) was propagated in 9-day-old
embryonic eggs, A/WSN/33 (H1N1) was rescued from
cDNA [49] and titrated on MDCK cells with plaque
assay. Recombinant adenoviruses were generated as
described by Luo [50], chCypA gene was subcloned into
shuttle vector pAdTrack-CMV, the resultant plasmid
was linearized by digesting with restriction endonuclease
PmeI and subsequently transformed into competent
AdEasier cells BJ5183, derivatives containing the adeno-
viral backbone plasmid pAdEasy-1. Recombinants were
selected for kanamycin resistance and recombination
was confirmed by restriction endonuclease analyses. The
confirmed recombinant adenovirus plasmids were
digested with PacI and transfected into 293A cells to
generate recombinant adenoviruses rAdchCypA carrying
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was verified by infection 293T/CypA- and detected by
Western blot with His-chCypA polyclonal antibodies.
Rabbit polyclonal antibodies against chCypA were gen-
erated by immunization of 2-month-old female rabbits
with 250 μg of purified hexahistidine-tagged chCypA
(His-chCypA) in Freund’s complete adjuvant; the gen-
eration of antibodies was boosted three times by immu-
nization with 150 μg of the protein at 2 week intervals.
Mouse anti-M1 monoclonal antibody was prepared as
described previously [7]. Anti-b-actin (Proteintech
group, Catalog No: 60008-1-Ig). C-Myc (9E10) antibo-
dies were purchased from Santa Cruz Biotechnology.
Mouse anti-FLAG (M2) antibody and anti-c-Myc poly-
clonal antibody were purchased from Sigma. TRITC-
conjugated anti-mouse IgG and FITC-conjugated anti-
rabbit IgG were purchased from Zhongshan Golden
Bridge Biotechnology, Beijing, China.
Isolation of full length chCypA ORF
Total RNA of 10-days SPF chicken embryo brain was
extracted using TRIzol (Invitrogen) reagent following
the protocol of manufacturer, and dissolved in DEPC
treated water and stored at -80°C. The First strand
cDNA of chCypA gene was synthesized by reverse tran-
scriptase (RT) using SuperScript III RT (Invitrogen) and
oligo (dT)12-18 as primer. The complete chCypA ORF
was amplified with PCR from first strand cDNA with
rTaq polymerase (TAKARA, Japan) and primers
chCypA-F: 5’ATGAATTCGGATGGCCAACCCCGT
CG-3’ and chCypA-R: 5’TGCTCGAGTTACGAGAG
CTGCCCGC-3’. The PCR amplified chCypA genes were
cloned into pCMV-Myc, pET- 30a, pGEX-4t-2 plasmids.
GST pull-down assays and Co-immunoprecipitation
GST pull-down and co-immunoprecipitation assays were
performed as described previously [7]. Briefly, Escheri-
chia coli BL21 (DE3)/pGEX-chCypA, was cultured to
mid-log phase at 37°C, isopropyl-1-thio-b-D-galactopya-
noside (IPTG) was then added and incubation was con-
tinued for another 8 h at 16°C to induce protein
expression. The bacteria was suspended in ice-cold
phosphate-buffered saline (PBS) (pH = 7.4), and homo-
genized by sonication. The lysate was then centrifuged
at 4000 g for 10 min at 4°C. The supernatants were
applied to a column containing 0.1 mL of sepharose 4B-
glutathione (AmershamP
Q6 Pharmacia Biotech). The
column was washed with 10 column volumes of PBS
buffer. An equal amount of either GST or GST-chCypA
(1 mg) bound to sepharose 4B-glutathione was mixed
w i t h1m go fp u r i f i e dh i s - M 1p r o t e i no r1 0 0μgo f
MDCK cell lysate infected with influenza A virus, and
incubated for 2 h at 4°C. The beads were washed five
times with washing buffer (1% NP40, 300 mM NaCl, 20
mM Hepes PH 7.4, 10% Glycerol, 1 mM EDTA) with
protease inhibitor cocktail (Roche). Proteins bound to
the beads were recovered by adding 2× SDS loading buf-
fer, boiled for 5 min and then analyzed by SDS-PAGE.
Proteins were then detected by Western blot with anti-
His-tag monoclonal antibody and anti-M1 monoclonal
antibody. To perform co-immunoprecipitation, cells
transient expression Myc-chCypA and FLAG-M1 pro-
teins were lysed in immunoprecipitation buffer, contain-
ing 0.5% NP40, 150 mM NaCl, 20 mM Hepes (PH 7.4),
10% Glycerol, 1 mM EDTA with protease inhibitor
cocktail. After centrifugation, the supernatant was incu-
bated with an anti-FLAG antibody (M2; Sigma) for 2 h.
Immune complexes were recovered by adsorption to
protein G-Sepharose resin (Amersham Biosciences).
After five times washes in immunoprecipitation buffer,
the immunoprecipitates were analyzed by Western blot.
Comparing intensity of bands on Western blot X-ray films
carried out with Photoshop program
The X-ray film of Western blot was scanned and saved
as a grayscale image with resolution to a medium value
500 dpi. Image was shown in Photoshop under Image >
Mode without color information. Invertion of the dark
p a r t sa n dl i g h tp a r t si ni m a g ew a sc a r r i e do u tu n d e r
Image > Adjustments. In this condition, the high-expres-
sion bands will have high numerical values when mea-
sured. The area of band was selected by drawing a line
around the edge of the band with lasso tool. The histo-
gram information of the band including a “Mean” value
and a “Pixels” value was recorded for the area within
your selection. Bands with high expression are typically
darker, but also often larger in size. The values for all
bands were entered in a spreadsheet. An integrated
measure of the intensity and size of the band was indi-
cated by multiplying the “Mean” value and a “Pixels”
value for each band. This integrated value was referred
to absolute intensity. Absolute intensity of each chCypA
band of different tissues was divided by the absolute
intensity of that in liver to come up with a relative
intensity for each sample band.
Generation of A/WSN/33 virus with 12 plasmids reverse
genetic system
293T/CypA- cells (1 × 10
6) were transfected with 12
plasmids reverse genetic system in different amounts
(0.1 μgp c D N A - P A ,o t h e r s1μg per plasmid) plus 4 μg
pCMV-Myc or pCMV-Myc-chCypA using transfect
reagent lipofectamine 2000 (invitrogen) according to the
manufacturer’s instructions. Briefly, DNA and transfec-
tion reagent were mixed (2.5 μL of lipofectamine 2000
per μg of DNA), incubated at room temperature for 20
min then added to the cells. Six hours later, the DNA-
transfection reagent mixture was replaced by Opti-MEM
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TPCK treated trypsin (sigma). 48 h after transfection,
the supernatant was harvested and A/WSN/33 virus
titer was measured with plaque assay on MDCK cells.
Indirect Immunofluorescence analysis
CEF cells were seeded on slides at 1 × 10
4 per well.
After the indicated treatment, cells were washed with
PBS and fixed in ice-cold 4% paraformaldehyde dis-
solved in PBS. Nonspecific binding was blocked with 4%
BSA in PBST (0.5% Triton). Fixed cells were incubated
with primary and secondary FITC-labelled (or TRITC-
labelled) antibodies as depicted. Cells nuclei were visua-
lized by DAPI staining and individual cells analyzed by
confocal fluorescence microscopy.
Real-time RT-PCR analysis of chCypA mRNA expression
Real time quantitative RT-PCR was performed with the
SYBR premix Ex taq (TaKaRa, Japan) on a corbett 6200
real time detection system (Corbett, Australia) to inves-
tigate the expression level change of chCypA in CEF
cells after influenza virus infection. Two chCypA pri-
mers chCypA-F: 5’CAAGACCGAGTGGTTGGACG3 ‘
chCypA-R: 5’CCGCAGTTGGAAATGGTGATC3 ‘ were
used to amplify a PCR product of 135 bp, b-actin (Gen-
Bank accession No. L08165) was chosen as reference
gene for internal standardization (primers sequences as
follow:
actinF: 5’CACAGATCATGTTTGAGACCTT3 ‘ actinR:
5’CATCACAATACCAGTGGTACG3’, primers M1F:
5’GGCTAAAGACAAGACCAATCCTG3’ and M1R:
5’GTCCTCGCTCACTGGGCAC3’ were used to amplify
an 87 bp fragment of segment 7 of influenza virus gen-
ome. The efficiencies of each primer set were calculated
from twofold serial dilution curves. The relative amounts
of mRNA were calculated by ΔΔCT method. The qRT-
PCR amplifications were carried out in triplicates in a
total volume of 20 μL containing 10 μL SYBR green 2 ×
premix, cDNA, primers (final concentration of 0.2 μM).
The PCR program was 95°C for 30 s followed by 40
cycles of 94°C for 5 s, 60°C for 30 s and dissociation
curve analysis of amplification products was performed
at the end of each PCR reaction to confirm that only one
PCR product was amplified and detected. Each sample
was run in triplicate along with the internal control gene.
Data analysis of real time PCR was performed with Rotor
Gene 6000 series Software (Corbett, Australia) and the
relative amounts of mRNA were calculated by ΔΔCT
method. CT difference between chCypA and b-actin
called ΔCT were calculated to normalize the differences
in the amount of total nucleic acid added to cDNA reac-
tion mixture and the efficiency of reverse transcription
reactions. The uninfected group was used as the refer-
ence sample, called the calibrator. The ΔΔCT for each
sample was subtracted from the ΔCT of the calibrator
and the difference was called ΔΔCT value, namely the
comparative CT. The relative expression level of chCypA
could be calculated by 2
-ΔΔCT, and the value stands for
an n-fold difference relative to the calibrator.
Plaque assay
Plaque assays were performed as described previously
[7]. MDCK cell monolayer (at a confluent of 100% in 12
well tissue culture plates) was washed with PBS and
incubated with different dilutions of virus for 1 h at 37°
C. The virus inoculation was removed and washed with
PBS. Cell monolayer was then overlaid with medium
(DMEM supplemented with 0.8% low-melting-point
agarose and 2 μg/mL TPCK-treated trypsin), when agar-
ose medium solidified, cell culture plate converted incu-
bated at 37°C. Visible plaques were counted at 4 days
post infection and virus titer was determined. All data
was expressed as the mean of three independent
experiments.
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